Medications for Tinea Versicolor
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Tinea Versicolor.
Found 5 Approved Drugs for Tinea Versicolor
Ecoza
Generic Name
Econazole
Ecoza
Generic Name
Econazole
Form: Cream, Aerosol
Method of administration: Topical
FDA approval date: November 26, 2002
Classification: Azole Antifungal
Econazole Nitrate Cream, 1% is indicated for topical application in the treatment of tinea pedis, tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, Microsporum canis, Microsporum audouini, Microsporum gypseum, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis, and in the treatment of tinea versicolor.
Ultramicrosize
Brand Names
Grisofulvin, Microsize, Fulvicin
Ultramicrosize
Brand Names
Grisofulvin, Microsize, Fulvicin
Form: Tablet, Suspension
Method of administration: Oral
FDA approval date: September 09, 1971
Classification: Tubulin Inhibiting Agent
Ultramicrosize griseofulvin tablets are indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete’s foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber’s itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis,Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton crateriform, Trichophyton sulphureum, Trichophyton schoenleini, Microsporum audouini, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum. NOTE: Prior to therapy, the type of fungi responsible for the infection should be identified. The use of the drug is not justified in minor or trivial infections which will respond to topical agents alone. Griseofulvin is not effective in the following: bacterial infections, candidiasis (moniliasis), histoplasmosis, actinomycosis, sporotrichosis, chromoblastomycosis, coccidioidomycosis, North American blastomycosis, cryptococcosis (torulosis), tinea versicolor and nocardiosis.
Ciclopirox Olamine
Generic Name
Ciclopirox Olamine
Ciclopirox Olamine
Generic Name
Ciclopirox Olamine
Form: Cream, Suspension
Method of administration: Topical
FDA approval date: April 12, 2005
Ciclopirox Olamine Topical Suspension USP.
Oxistat
Generic Name
Oxiconazole
Oxistat
Generic Name
Oxiconazole
Form: Lotion, Cream
Method of administration: Topical
FDA approval date: March 07, 2016
Classification: Azole Antifungal
Oxiconazole nitrate cream is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum. Oxiconazole nitrate cream is indicated for the topical treatment of tinea (pityriasis) versicolor due to Malassezia furfur. Oxiconazole nitrate cream may be used in pediatric patients for tinea corporis, tinea cruris, tinea pedis, and tinea (pityriasis) versicolor; however, these indications for which oxiconazole nitrate cream has been shown to be effective rarely occur in children below the age of 12.
Exelderm
Generic Name
Sulconazole
Exelderm
Generic Name
Sulconazole
Form: Cream, Solution
Method of administration: Topical
FDA approval date: June 07, 2019
Classification: Azole Antifungal
EXELDERM (sulconazole nitrate, USP) SOLUTION, 1.0% is a broad-spectrum antifungal agent indicated for the treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; and for the treatment of tinea versicolor. Effectiveness has not been proven in tinea pedis (athlete's foot). Symptomatic relief usually occurs within a few days after starting EXELDERM SOLUTION and clinical improvement usually occurs within one week.
Showing 1-5 of 5
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances